NN$45.71
-4.61 (-9.16%) · last close
NNNovo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
Company background via Wikipedia and Wikidata.
The second incretin leg, held at a discount after estimate resets.